EFTA01017687.pdf

From: Boris Nikolic To: ' c > CC: lieevacation(ref,grnail.com" <jeevacationggrnail.com> Subject: RE: Re: Date: Sat, 03 Nov 2018 23:15:07 +0000 Hi Harry Please let me double check this. There are many projects that BMGF specifically do not fund directly (especially if it has to do with a delivery, procurement etc) but through partners such as PATH, PSI etc. There are some projects that BMGF funded a lot such a male circumcision but got eventually transferred to the partners. It will take me few days to find out as I do not know the new director of Reproductive Health (they changed few since I left!) and strangely RH is a part of global development (not a Global Health). Please ping me in a week or so. Best Boris From: > Sent: Saturday, November 3, 2018 2:32 PM To: Boris Nikolic < Cc: [email protected] Subject: Re: Hi Boris Currently The Female Health division of VERU supplies approximately 50 million Female Condoms worldwide. BMGF has never funded the FC2 Female condom. I don't know why this is the case. The FC2 female condom is the most demanded and utilized female condom worldwide. It is supplied throughout Africa via UNFPA and bought directly by South Africa. Funding by UNFPA has dramatically decreased and we are unable to supply certain countries that have requested the female condom. For example, the following countries have requested the FC2 female condom but we are unable to supply: Uganda : 3 million units Ghana: 1 million units Botswana: 1 million units Tunesia: 1 million units Sierra Leone: 500,000 units Bolivia: 500,000 units Tanzania: 1 million units Haiti: 500,000 units Ethiopia: 1 million units EFTA01017687 Congo DR: 2 million units Boris, can you introduce me to the right person at BMGF to see if we can get grants to provide FC2 female condoms to all women who request them in Africa. Also attached is more information regarding the FC2 female condom. Would like to continue the conversation. Sincerely, Harry Original Message From: Boris Nikolic < To: harryfisch < Cc: jeevacation <[email protected]> Sent: Sat, Nov 3, 2018 1:27 pm Subject: RE: Re: Thank you Harry! Again — great meeting you. I am still laughing re inherited STD. Finally I had chance to read your slide deck. VERU is indeed very interesting company — congrats! You have an interesting mix of Urology specialty drugs (which I see as a low risk) and Prostate cancer drugs. Unfortunately my fund (https://www.biomaticscapital.comi) is only focused (and restricted to investing) on private companies. Mid-end of the next year I am going to fundraise a crossover fund which would allow me to invest in both private and publicly listed companies; nevertheless, I am now unable to invest in companies such as VERU — despite how interesting they might be. I looked at a female condom. I think that PATH supported a number of related projects. https://www.path.org/articles/seven-secrets-of-the-female-condom/ As you might know BMGF is the main donor to PATH — this is why I mentioned it. Also BMGF founded several smaller grants (GCE) re female condoms https://www.gatesfoundation.org/Media- Center/Press-Releases/2014/06/GCE-Round-12 In addition, there were grants to Imperial College in London, HealthRock etc. All of these are relatively old grants that ended. My guess is that all female condom more mature projects transitioned to PATH. Also I see that PSI has been funding marketing and delivery https://www.psi.org/2018/03/fresh-start-female-condom- marketing( Please let me know if there is anything else I can be of help to you. Hope to see you soon in NYC Best Boris EFTA01017688 From: Sent: Thursday, November 1, 2018 5:34 PM To: Boris Nikolic [email protected] Subject: Re: Jeffrey thanks for introducing me to Boris. Boris, great meeting you as well. Attached is the most recent deck for VERU (NASDAQ: VERU) www.verupharma.com . In addition please look at www.femalecondom.com. We merged with The Female Health Company which sells the FC2 Female Condom to the public sector in Africa and Brazil via UNFPA and USAID. We just recently introduced this condom into the US market mainly via telemedicine. Would love to meet and discuss further. Sincerely, Harry Harry Fisch MD cell 914-552-2651 ----Original Message From: Boris Nikolic To: J <jeevacation(Wgmail.com>: Harry Fisch < Sent: Thu, Nov 1, 2018 4:13 pm Subject: RE: Thank you J! Great meeting you Harry! Looking forward to seeing you again. Please send me something re your company. Best Boris From: J <[email protected]> Sent: Thursday, November 1, 2018 3:15 PM To: Boris Nikolic < Harry Fisch < Subject: harry boris, boris harry please note The information contained in this communication is confidential, may be attorney-client privileged, may constitute inside information, and is intended only for the use of the addressee. It is the property of JEE Unauthorized use, disclosure or copying of this communication or any part thereof is strictly prohibited and may be unlawful. If you have received this communication in error, please notify us immediately by EFTA01017689 return e-mail or by e-mail [email protected]. and destroy this communication and all copies thereof, including all attachments. copyright -all rights reserved EFTA01017690